Emergent BioSolutions Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022
For the year, the company expects CDMO Revenues to be $105-$125 million and total revenues to be $1,150-$1,250 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.185 USD | -4.59% | +13.42% | -10.21% |
1st Jan change | Capi. | |
---|---|---|
-10.21% | 120M | |
+25.51% | 672B | |
+25.87% | 570B | |
-5.30% | 360B | |
+16.74% | 321B | |
+8.39% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.69% | 149B |